Efficacy and safety of gemigliptin in patients with type 2 diabetes

被引:0
|
作者
Yang, S. J. [1 ]
Min, K. W. [2 ]
Park, J. Y. [3 ]
Kim, D. M. [4 ]
Kim, Y. S. [5 ]
Gupta, S. K. [6 ]
Shivane, V. K. [7 ]
Pitale, S. [8 ]
Agarwal, P. K. [9 ]
Sosale, A. R. [10 ]
Dharmalingam, M. [11 ]
Gandhi, P. [12 ]
Mohan, V. [13 ]
Kim, J. A. [14 ]
Baik, S. H. [1 ]
机构
[1] Korea Univ, Guro Hosp, Seoul, South Korea
[2] Eulji Med Ctr, Med Corp, Seoul, South Korea
[3] Asan Publ Welf Fdn, Asan Med Ctr, Seoul, South Korea
[4] Kangdong Sacred Heart Hosp, Seoul, South Korea
[5] Inha Univ Hosp, Inchon, South Korea
[6] MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India
[7] RHIDEM, Mumbai, Maharashtra, India
[8] Pitale Diabet & Hormone Ctr, Nagpur, Maharashtra, India
[9] Hormone Care & Res Ctr, Ghaziabad, India
[10] Diacon Hosp, Diabet Care & Res Ctr, Bangalore, Karnataka, India
[11] Bangalore Endocrinol & Diabet Res Ctr, Bangalore, Karnataka, India
[12] Gandhi Res Inst, Nagpur, Maharashtra, India
[13] Madras Diabet Res Fdn, Madras, Tamil Nadu, India
[14] LG Life Sci, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
851
引用
收藏
页码:S351 / S352
页数:2
相关论文
共 50 条
  • [1] Efficacy and Safety of Gemigliptin in Patients With Type 2 Diabetes
    Yang, Sae Jeong
    Min, Kyung Wan
    Park, Joong Yeol
    Kim, Do-Man
    Kim, Yong Seong
    Gupta, Sandeep Kumar
    Shivane, Vyankatesh K.
    Pitale, Shailesh
    Agarwal, Pankaj Kumar
    Sosale, Aravind R.
    Dharmal-Ingam, Mala
    Gandhi, Pramod
    Mohan, V.
    Mahesh, Uma
    Kim, Jeong Ae
    Kim, Pan Kyung
    Baik, Sei Hyun
    DIABETES, 2012, 61 : A594 - A594
  • [2] Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus
    Bae, Jaehyun
    Kim, Youjin
    Cho, Yongin
    Lee, Minyoung
    Lee, Ji-Yeon
    Lee, Yong-ho
    Lee, Byung-Wan
    Cha, Bong-Soo
    Joo, Dong Jin
    Huh, Kyu Ha
    Kim, Myoung Soo
    Kim, Yu Seun
    Kang, Eun Seok
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (10) : 3444 - 3448
  • [3] Efficacy and safety of gemigliptin in type 2 diabetes patients with moderate to severe renal impairment
    Yoon, Sun Ae
    Han, Byoung Geun
    Kim, Sung Gyun
    Han, Sang Youb
    Jo, Young-Il
    Jeong, Kyung Hwan
    OH, Kook-Hwan
    Park, Hyoungchun
    Park, Sun-Hee
    Kang, Shin-Wook
    Na, Ki-Ryang
    Kang, Sun Woo
    Kim, Nam-Ho
    Jang, YoungHwan
    Kim, Sung-Ho
    Cha, Dae Ryong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S126 - S126
  • [4] Efficacy and Safety of Gemigliptin in Type 2 Diabetes Patients with Moderate to Severe Renal Impairment
    Yoon, Sun Ae
    Han, Byoung Geun
    Kim, Sung Gyun
    Han, Sang Youb
    Jo, Young-Il
    Jeong, Kyung Hwan
    Oh, Kook-Hwan
    Park, Hyoungchun
    Park, Sun-Hee
    Kang, Shin-Wook
    Na, Ki-Ryang
    Kang, Sun Woo
    Kim, Nam-Ho
    Kim, Sung-Ho
    Jang, Younghwan
    Cha, Dae Ryong
    DIABETES, 2016, 65 : A314 - A315
  • [5] Efficacy and safety of gemigliptin in type 2 diabetes patients with moderate to severe renal impairment
    Yoon, S.
    Han, B.
    Kim, S.
    Han, S.
    Jo, Y. -I.
    Jeong, K.
    Oh, K. -H.
    Park, H.
    Park, S. -H.
    Kang, S. -W.
    Na, K. -R.
    Jang, Y.
    Kim, S. -H.
    Cha, D.
    DIABETOLOGIA, 2015, 58 : S387 - S387
  • [6] Efficacy and safety of gemigliptin in type 2 diabetes patients with moderate to severe renal impairment (GUARD study)
    Yoon, S.
    Han, B.
    Kim, S.
    Han, S.
    Jo, Y-I.
    Jeong, K.
    Oh, K. -H.
    Park, H.
    Park, S. -H.
    Kang, S. -W.
    Na, K. -R.
    Jang, Y.
    Kim, S. -H.
    Cha, D.
    DIABETOLOGIA, 2016, 59 : S361 - S362
  • [7] Efficacy and Safety of Gemigliptin as Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on Metformin and Glimepiride
    Han, Kyung Ah
    Yu, Jae Myung
    Jang, Hak Chul
    Ahn, Kyu Jeung
    Oh, Takkeun
    Lee, Hyoung Woo
    Lee, Daeho
    Kim, Jae Taek
    Park, Tae Sun
    Nam, Joo Young
    Chung, Choon Hee
    Kim, Byung-Joon
    Park, Seok Won
    Kim, Sung-Ho
    Park, Kyong Soo
    DIABETES, 2016, 65 : A307 - A307
  • [8] Efficacy and safety of gemigliptin as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin and glimepiride
    Kim, S. -H.
    Yu, J.
    Jang, H.
    Song, Y.
    Ahn, K.
    Oh, T.
    Lee, H.
    Lee, D.
    Kim, J.
    Park, T. -S.
    Jeong, C. -H.
    Kim, B. -J.
    Han, K.
    Park, K.
    DIABETOLOGIA, 2016, 59 : S357 - S357
  • [9] Efficacy and safety of gemigliptin as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin and glimepiride
    Han, Kyung Ah
    Yu, Jae Myung
    Jang, Hak Chul
    Song, Young Duk
    Ahn, Kyu Jeung
    Oh, Takkeun
    Lee, Hyoung Woo
    Lee, Daeho
    Kim, Jae Taek
    Jeong, Choon-hee
    Kim, Byoung-joon
    Park, Kyong Soo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S125 - S126
  • [10] Efficacy and safety of gemigliptin as add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study)
    Cho, Young Min
    Deerochanawong, Chaicharn
    Seekaew, Samroeng
    Suraamornkul, Swangjit
    Benjachareonwong, Sunun
    Sattanon, Sarinya
    Chamnan, Parinya
    Sirirak, Thanitha
    Kosachunhanun, Natapong
    Pratipanawatr, Thongchai
    Suwanwalaikorn, Sompongse
    Lee, Woo Je
    Kim, Sungrae
    Choi, Seonghui
    Kang, Eun Seok
    Oh, Taekeun
    Kwon, Sam
    Lee, Moon-Kyu
    DIABETES OBESITY & METABOLISM, 2020, 22 (01): : 123 - 127